Titan Biotech Limited (BOM:524717)
India · Delayed Price · Currency is INR 297.80
+21.55 (7.80%)
At close: Mar 9, 2026
Titan Biotech Revenue
Titan Biotech had revenue of 565.06M INR in the quarter ending December 31, 2025, with 47.63% growth. This brings the company's revenue in the last twelve months to 1.93B, up 19.43% year-over-year. In the fiscal year ending March 31, 2025, Titan Biotech had annual revenue of 1.56B, down -4.65%.
Revenue (ttm)
1.93B
Revenue Growth
+19.43%
P/S Ratio
6.39
Revenue / Employee
4.12M
Employees
467
Market Cap
12.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.56B | -76.21M | -4.65% |
| Mar 31, 2024 | 1.64B | 200.73M | 13.94% |
| Mar 31, 2023 | 1.44B | 204.50M | 16.55% |
| Mar 31, 2022 | 1.24B | -186.92M | -13.14% |
| Mar 31, 2021 | 1.42B | 628.00M | 79.05% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Southern Petrochemical Industries Corporation | 31.26B |
| Chaman Lal Setia Exports | 13.79B |
| TTK Healthcare | 8.30B |
| Atul Auto | 7.92B |
| Ultramarine & Pigments | 7.71B |
| Lincoln Pharmaceuticals | 6.52B |
| GOCL Corporation | 5.50B |
| R & B Denims | 4.28B |